ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of June

June 27, 2014

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Organization Can Compete For Both Major FCRC Contracts, RFP Out Next June

September 12, 1980

NCI Offers Bibliography On Risk Communication.

March 23, 2001

Department of Defense Offering $16 Million in Cancer Research Grants

July 22, 2011